Cargando…
Elotuzumab spares dendritic cell integrity and functionality
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164573/ https://www.ncbi.nlm.nih.gov/pubmed/33651141 http://dx.doi.org/10.1007/s00432-021-03572-z |
| _version_ | 1783701145321996288 |
|---|---|
| author | Schlaweck, Sebastian Strauss, Leon Daecke, Solveig Brossart, Peter Heine, Annkristin |
| author_facet | Schlaweck, Sebastian Strauss, Leon Daecke, Solveig Brossart, Peter Heine, Annkristin |
| author_sort | Schlaweck, Sebastian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8164573 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81645732021-06-17 Elotuzumab spares dendritic cell integrity and functionality Schlaweck, Sebastian Strauss, Leon Daecke, Solveig Brossart, Peter Heine, Annkristin J Cancer Res Clin Oncol Letter to the Editor Springer Berlin Heidelberg 2021-03-02 2021 /pmc/articles/PMC8164573/ /pubmed/33651141 http://dx.doi.org/10.1007/s00432-021-03572-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Schlaweck, Sebastian Strauss, Leon Daecke, Solveig Brossart, Peter Heine, Annkristin Elotuzumab spares dendritic cell integrity and functionality |
| title | Elotuzumab spares dendritic cell integrity and functionality |
| title_full | Elotuzumab spares dendritic cell integrity and functionality |
| title_fullStr | Elotuzumab spares dendritic cell integrity and functionality |
| title_full_unstemmed | Elotuzumab spares dendritic cell integrity and functionality |
| title_short | Elotuzumab spares dendritic cell integrity and functionality |
| title_sort | elotuzumab spares dendritic cell integrity and functionality |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164573/ https://www.ncbi.nlm.nih.gov/pubmed/33651141 http://dx.doi.org/10.1007/s00432-021-03572-z |
| work_keys_str_mv | AT schlawecksebastian elotuzumabsparesdendriticcellintegrityandfunctionality AT straussleon elotuzumabsparesdendriticcellintegrityandfunctionality AT daeckesolveig elotuzumabsparesdendriticcellintegrityandfunctionality AT brossartpeter elotuzumabsparesdendriticcellintegrityandfunctionality AT heineannkristin elotuzumabsparesdendriticcellintegrityandfunctionality |